Ownership history in RENAISSANCE TECHNOLOGIES LLC · 91 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,909,259 | -264,133 | -12.2% | 1.44% | $930.3M | $487.25 |
| 2025 Q3 | ADDED | 2,173,392 | +54,300 | +2.6% | 1.20% | $911.1M | $419.21 |
| 2025 Q2 | ADDED | 2,119,092 | +12,100 | +0.6% | 0.81% | $608.9M | $287.35 |
| 2025 Q1 | ADDED | 2,106,992 | +17,600 | +0.8% | 0.98% | $649.5M | $308.27 |
| 2024 Q4 | REDUCED | 2,089,392 | -66,000 | -3.1% | 1.09% | $737.2M | $352.84 |
| 2024 Q3 | REDUCED | 2,155,392 | -19,300 | -0.9% | 1.16% | $772.4M | $358.35 |
| 2024 Q2 | ADDED | 2,174,692 | +22,978 | +1.1% | 1.17% | $692.7M | $318.55 |
| 2024 Q1 | REDUCED | 2,151,714 | -18,500 | -0.9% | 0.78% | $494.3M | $229.72 |
| 2023 Q4 | REDUCED | 2,170,214 | -80,294 | -3.6% | 0.74% | $477.2M | $219.89 |
| 2023 Q3 | ADDED | 2,250,508 | +63,294 | +2.9% | 0.87% | $508.3M | $225.87 |
As of 2025 Q4 — sorted by position size